Mohammad Owais

6.5k total citations
211 papers, 5.0k citations indexed

About

Mohammad Owais is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Mohammad Owais has authored 211 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 39 papers in Immunology and 36 papers in Infectious Diseases. Recurrent topics in Mohammad Owais's work include Synthesis and biological activity (19 papers), Antifungal resistance and susceptibility (18 papers) and Nanoparticles: synthesis and applications (17 papers). Mohammad Owais is often cited by papers focused on Synthesis and biological activity (19 papers), Antifungal resistance and susceptibility (18 papers) and Nanoparticles: synthesis and applications (17 papers). Mohammad Owais collaborates with scholars based in India, Saudi Arabia and United States. Mohammad Owais's co-authors include Mohammad Asif Sherwani, Farrukh Aqil, Chhitar M. Gupta, Syed Mohd Faisal, Iqbal Ahmad, Mohd Ahmar Rauf, M. Saleemuddin, Mohammad Shakir, Masood Alam Khan and Aijaz Ahmed Khan and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mohammad Owais

202 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mohammad Owais India 36 1.3k 836 835 734 529 211 5.0k
Ahmad Almatroudi Saudi Arabia 43 1.9k 1.5× 984 1.2× 355 0.4× 636 0.9× 275 0.5× 204 5.8k
M. Moshahid A. Rizvi India 36 1.5k 1.2× 382 0.5× 791 0.9× 333 0.5× 389 0.7× 188 4.6k
Won Fen Wong Malaysia 37 2.0k 1.5× 351 0.4× 492 0.6× 478 0.7× 642 1.2× 112 5.9k
Mark A. T. Blaskovich Australia 46 3.0k 2.3× 811 1.0× 2.0k 2.4× 701 1.0× 383 0.7× 159 7.5k
Vandana Patravale India 50 2.4k 1.8× 757 0.9× 672 0.8× 1.1k 1.5× 450 0.9× 221 8.9k
Cristina Rodrı́guez-Padilla Mexico 31 1.7k 1.3× 827 1.0× 192 0.2× 593 0.8× 733 1.4× 206 4.8k
Abdelwahab Omri Canada 45 2.0k 1.5× 497 0.6× 396 0.5× 704 1.0× 402 0.8× 128 5.5k
Wojciech Kamysz Poland 42 2.7k 2.1× 319 0.4× 608 0.7× 856 1.2× 566 1.1× 225 5.8k
Horacio Bach Canada 37 2.0k 1.5× 2.2k 2.7× 457 0.5× 1.5k 2.0× 401 0.8× 134 6.9k
Zyta M. Ziora Australia 32 941 0.7× 595 0.7× 717 0.9× 458 0.6× 201 0.4× 84 3.5k

Countries citing papers authored by Mohammad Owais

Since Specialization
Citations

This map shows the geographic impact of Mohammad Owais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Owais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Owais more than expected).

Fields of papers citing papers by Mohammad Owais

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Owais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Owais. The network helps show where Mohammad Owais may publish in the future.

Co-authorship network of co-authors of Mohammad Owais

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Owais. A scholar is included among the top collaborators of Mohammad Owais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Owais. Mohammad Owais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Masood Alam, et al.. (2025). Targeting Azole-Resistant Candida albicans: Tetrapeptide Tuftsin-Modified Liposomal Vaccine Induces Superior Immune Protection. Vaccines. 13(6). 630–630. 1 indexed citations
2.
3.
Malik, Jonaid Ahmad, et al.. (2024). Immunosuppressive effects of morphine on macrophage polarization and function. European Journal of Pharmacology. 975. 176637–176637. 11 indexed citations
5.
Saigal, Saigal, Mohammad Owais, Akil Ahmad, et al.. (2024). Coumarin 1,4-dihydropyridine hybrids: Synthesis, X-ray structure, cytotoxicity assay, and molecular dynamic simulation studies. Journal of Molecular Structure. 1327. 141155–141155.
6.
Jolly, Reshma, et al.. (2023). Combinatorial approach to fabricate silica doped polyvinyl alcohol/hydroxyapatite/carrageenan nanocomposite for bone regeneration applications. Polymers for Advanced Technologies. 34(7). 2272–2285. 2 indexed citations
7.
Farazuddin, Mohammad, Qamar Zia, Asim Azhar, et al.. (2023). Potential of siRNA-Bearing Subtilosomes in the Treatment of Diethylnitrosamine-Induced Hepatocellular Carcinoma. Molecules. 28(5). 2191–2191. 5 indexed citations
9.
Khan, Mir Azam, Parul Singh, Yahya F. Jamous, et al.. (2022). Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. Cancers. 15(1). 249–249. 13 indexed citations
10.
12.
Khan, Mir Azam, Shahab Uddin, Abozer Y. Elderdery, et al.. (2022). Illuminating the Molecular Intricacies of Exosomes and ncRNAs in Cardiovascular Diseases: Prospective Therapeutic and Biomarker Potential. Cells. 11(22). 3664–3664. 5 indexed citations
13.
Khan, Mohammad Irfan, et al.. (2021). An insight on safety, efficacy, and molecular docking study reports of N-acetylcysteine and its compound formulations. Journal of Basic and Clinical Physiology and Pharmacology. 33(3). 223–233. 6 indexed citations
15.
Jolly, Reshma, et al.. (2020). Hydroxyapatite Nanoparticles Fortified Xanthan Gum–Chitosan Based Polyelectrolyte Complex Scaffolds for Supporting the Osteo-Friendly Environment. ACS Applied Bio Materials. 3(10). 7133–7146. 22 indexed citations
17.
Aslam, M., et al.. (2010). Correlation between tumour necrosis factor-alpha and other co-variates and different grades of blood pressure in essential hypertensive patients.. Biomedical Research-tokyo. 21(2). 0. 3 indexed citations
18.
Khan, Masood Alam, Nadeem Ahmad, Shagufta Moin, et al.. (2005). Tuftsin-mediated immunoprophylaxis against an isolate ofAspergillus fumigatusshows less in vivo susceptibility to amphotericin B. FEMS Immunology & Medical Microbiology. 44(3). 269–276. 5 indexed citations
19.
Owais, Mohammad, Shailja Misra‐Bhattacharya, W. Haq, & Chhitar M. Gupta. (2003). Immunomodulator Tuftsin Augments Antifilarial Activity of Diethylcarbamazine Against Experimental Brugian Filariasis. Journal of drug targeting. 11(4). 247–251. 24 indexed citations
20.
Faisal, Syed Mohd, et al.. (2002). Immunomodulator Tuftsin Augments Anti-fungal Activity of Amphotericin B Against Experimental Murine Candidiasis. Journal of drug targeting. 10(3). 185–192. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026